CALEYCOM LIMITED
Company number SC384645 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
1. Financial Health Score: F (Terminal/Deceased)
While the company’s final financial statements from 2021 show a business that had recovered from a prior near-death experience, the ultimate diagnosis must be an "F." A company with a "Dissolved" status no longer has a pulse; its corporate life has ceased, and it is no longer legally operating. However, examining the historical vital signs provides a fascinating clinical picture of a business that survived a severe hemorrhage, only to eventually succumb to a different condition.
2. Key Vital Signs
- The "Heartbeat" (Net Assets/Equity): In 2021, the company's net assets were £33,966, up from £30,933 in 2020. This indicates a positive, beating heartbeat in its final year. This is a remarkable recovery considering the flatline in 2014, when net assets were a negative £17,521.
- "Blood Pressure" (Leverage & Liabilities): In 2021, total liabilities surged to £25,745, up significantly from £9,823 in 2020. While total assets also grew to £59,711, this sudden spike in "blood pressure" (debt) suggests the company was aggressively leveraging itself, likely taking on short-term creditors to finance operations or asset purchases.
- "Respiratory Rate" (Liquidity/Working Capital): Net current assets (working capital) dropped from £15,026 in 2020 to £10,380 in 2021. While the company was still breathing comfortably enough to meet its short-term obligations, its respiratory capacity was shrinking just before dissolution.
- Historical "Trauma" (The 2014 Hemorrhage): The financial history reveals a severe financial hemorrhage in 2013-2014. In 2014, current liabilities dwarfed current assets, and the company sat in negative equity (£-17,521). The business survived this trauma, likely through a capital transfusion or debt forgiveness in 2015, which restored it to positive equity (£15,413).
3. Diagnosis
Symptoms Analysis: The financial data reveals a business that was a "walking wounded" survivor of a past insolvency crisis. The 2014 period showed classic symptoms of distress: negative net assets and cash reserves dwindling to just £645. The recovery from 2015 onwards was steady, showing a business that had stabilized.
However, the final year (2021) presented worrying symptoms of a potential relapse. The company took on a significant amount of new short-term debt (creditors due within one year jumped by over £15,000). Simultaneously, fixed assets grew from £15,907 to £23,586. This suggests the company may have been investing in equipment or other fixed assets using short-term credit—a dangerous financial arrhythmia that restricts cash flow flexibility.
Overall Diagnosis: The patient ultimately did not survive. Despite recovering from a critical insolvency event in 2014, the company entered a dissolved state. The sudden increase in short-term liabilities in its final year suggests the business may have faced cash flow difficulties or an unsustainable debt load that led to its closure, or it was simply wound up as no longer viable.
4. Recommendations
Because Caleycom Limited is dissolved, no treatment plan can revive this specific patient. However, for the director and person with significant control, Mr. Graham Shaw Porteous, the following preventative care recommendations apply to future business ventures:
- Avoid Financing Long-Term Assets with Short-Term Debt: The 2021 accounts suggest fixed assets were acquired using short-term credit. This misalignment starves the business of operating cash. Future ventures should match the lifespan of the asset with the lifespan of the financing (e.g., using long-term loans for long-term assets).
- Maintain a Healthy "Emergency Fund": The 2014 crisis showed how quickly a business can hemorrhage cash when liabilities outpace assets. Keeping a robust cash reserve will prevent the need for emergency, high-pressure borrowing.
- Monitor "Blood Pressure" Regularly: The jump in creditors from £9.8k to £25.7k in a single year is a severe symptom that should trigger immediate strategic review. In future enterprises, establish strict debt-to-equity thresholds and halt borrowing when those limits are approached.